Top

Published in:

29-05-2023 | Prostatectomy | Research

Robot-assisted radical prostatectomy following holmium laser enucleation of the prostate: perioperative, functional, and oncological outcomes

Authors: Taro Banno, Kazutaka Nakamura, Akihiko Ozaki, Yukiko Kouchi, Tadashi Ohira, Hiroaki Shimmura

Published in: Journal of Robotic Surgery | Issue 5/2023

Abstract

Robot-assisted radical prostatectomy with previous holmium laser enucleation of the prostate is challenging, and few studies have analyzed its perioperative, functional, and oncological outcomes. Here we retrospectively evaluated 298 robot-assisted radical prostatectomies, including 25 with and 273 without previous holmium laser enucleation of the prostate, performed in 2015–2022. Regarding perioperative outcomes, operative and console times were significantly longer in the previous holmium laser enucleation of the prostate group. In contrast, the estimated blood loss was similar between groups, and there were no transfusions or intraoperative complications. Multivariable Cox hazard regression analysis of the functional outcomes of postoperative urinary continence showed that body mass index, intraoperative bladder neck repair, and nerve sparing were independently associated factors, whereas a history of holmium laser enucleation of the prostate was not. Similarly, a history of holmium laser enucleation of the prostate was not associated with biochemical recurrence; however, positive surgical margins and seminal vesicle invasion were independent risk factors of biochemical recurrence. Our findings revealed that robot-assisted radical prostatectomy after holmium laser enucleation of the prostate was safe and raised no concerns of postoperative urinary incontinence or biochemical recurrence. Therefore, robot-assisted radical prostatectomy may be a treatment option for patients with prostate cancer after holmium laser enucleation of the prostate.

Pernar CH, Ebot EM, Wilson KM, Mucci LA (2018) The epidemiology of prostate cancer. Cold Spring Harb Perspect Med. https://doi.org/10.1101/cshperspect.a030361CrossRefPubMedPubMedCentral

Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, Freedland SJ, Greene K, Klotz LH, Makarov DV, Nelson JB, Rodrigues G, Sandler HM, Taplin ME, Treadwell JR (2018) Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part II: recommended approaches and details of specific care options. J Urol 199:990–997. https://doi.org/10.1016/j.juro.2018.01.002CrossRefPubMed

Cao L, Yang Z, Qi L, Chen M (2019) Robot-assisted and laparoscopic vs open radical prostatectomy in clinically localized prostate cancer: perioperative, functional, and oncological outcomes: a systematic review and meta-analysis. Med (Baltim) 98:e15770. https://doi.org/10.1097/MD.0000000000015770CrossRef

Avulova S, Zhao Z, Lee D, Huang LC, Koyama T, Hoffman KE, Conwill RM, Wu XC, Chen V, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Resnick MJ, Penson DF, Barocas DA (2018) The effect of nerve sparing status on sexual and urinary function: 3-year results from the CEASAR study. J Urol 199:1202–1209. https://doi.org/10.1016/j.juro.2017.12.037CrossRefPubMed

Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, Menon M, Montorsi F, Patel VR, Stolzenburg JU, Van der Poel H, Wilson TG, Zattoni F, Mottrie A (2012) Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 62:405–417. https://doi.org/10.1016/j.eururo.2012.05.045CrossRefPubMed

Le Duc A, Gilling PJ (1999) Holmium laser resection of the prostate. Eur Urol 35:155–160. https://doi.org/10.1159/000019836CrossRefPubMed

Abedi A, Razzaghi MR, Rahavian A, Hazrati E, Aliakbari F, Vahedisoraki V, Allameh F (2020) Is holmium laser enucleation of the prostate a good surgical alternative in benign prostatic hyperplasia management? A review article. J Lasers Med Sci 11:197–203. https://doi.org/10.34172/jlms.2020.33CrossRefPubMedPubMedCentral

Takamori H, Masumori N, Kamoto T (2017) Surgical procedures for benign prostatic hyperplasia: a nationwide survey in Japan, 2014 update. Int J Urol 24:476–477. https://doi.org/10.1111/iju.13344CrossRefPubMed

Nunez R, Hurd KJ, Noble BN, Castle EP, Andrews PE, Humphreys MR (2011) Incidental prostate cancer revisited: early outcomes after holmium laser enucleation of the prostate. Int J Urol 18:543–547. https://doi.org/10.1111/j.1442-2042.2011.02776.xCrossRefPubMed

10.

Kim M, Song SH, Ku JH, Oh SJ, Paick JS (2014) Prostate cancer detected after holmium laser enucleation of prostate (HoLEP): significance of transrectal ultrasonography. Int Urol Nephrol 46:2079–2085. https://doi.org/10.1007/s11255-014-0777-zCrossRefPubMed

11.

Elkoushy MA, Elshal AM, Elhilali MM (2015) Incidental prostate cancer diagnosis during holmium laser enucleation: assessment of predictors, survival, and disease progression. Urology 86:552–557. https://doi.org/10.1016/j.urology.2015.06.002CrossRefPubMed

12.

Otsubo S, Yokomizo A, Mochida O, Shiota M, Tatsugami K, Inokuchi J, Naito S (2015) Significance of prostate-specific antigen-related factors in incidental prostate cancer treated by holmium laser enucleation of the prostate. World J Urol 33:329–333. https://doi.org/10.1007/s00345-014-1310-9CrossRefPubMed

13.

Bhojani N, Boris RS, Monn MF, Mandeville JA, Lingeman JE (2015) Coexisting prostate cancer found at the time of holmium laser enucleation of the prostate for benign prostatic hyperplasia: predicting its presence and grade in analyzed tissue. J Endourol 29:41–46. https://doi.org/10.1089/end.2014.0359CrossRefPubMed

14.

Ohwaki K, Endo F, Shimbo M, Fujisaki A, Hattori K (2017) Comorbidities as predictors of incidental prostate cancer after holmium laser enucleation of the prostate: diabetes and high-risk cancer. Aging Male 20:257–260. https://doi.org/10.1080/13685538.2017.1301417CrossRefPubMed

15.

Tominaga Y, Sadahira T, Mitsui Y, Maruyama Y, Tanimoto R, Wada K, Munemasa S, Kusaka N, Nishiyama Y, Kurashige T, Nasu Y, Hayata S (2019) Favorable long-term oncological and urinary outcomes of incidental prostate cancer following holmium laser enucleation of the prostate. Mol Clin Oncol 10:605–609. https://doi.org/10.3892/mco.2019.1839CrossRefPubMedPubMedCentral

16.

Magistro G, Keller P, Westhofen T, Schott M, Tamalunas A, Weinhold P, Stief CG (2021) The significance of a high preoperative PSA level for the detection of incidental prostate cancer in LUTS patients with large prostates. World J Urol 39:1481–1487. https://doi.org/10.1007/s00345-020-03321-wCrossRefPubMed

17.

Gellhaus PT, Monn MF, Leese J, Flack CK, Lingeman JE, Koch MO, Boris RS (2015) Robot-assisted radical prostatectomy in patients with a history of holmium laser enucleation of the prostate: feasibility and evaluation of initial outcomes. J Endourol 29:764–769. https://doi.org/10.1089/end.2014.0767CrossRefPubMed

18.

Abedali ZA, Calaway AC, Large T, Koch MO, Lingeman JE, Boris RS (2020) Robot-assisted radical prostatectomy in patients with a history of holmium laser enucleation of the prostate: the Indiana University experience. J Endourol 34:163–168. https://doi.org/10.1089/end.2019.0436CrossRefPubMed

19.

Menon M, Tewari A, Peabody J, VIP Team (2003) Vattikuti Institute prostatectomy: technique. J Urol 169:2289–2292. https://doi.org/10.1097/01.ju.0000067464.53313.ddCrossRef

20.

Kaul S, Menon M (2006) Robotic radical prostatectomy: evolution from conventional to VIP. World J Urol 24:152–160. https://doi.org/10.1007/s00345-006-0101-3CrossRefPubMed

21.

Rocco F, Carmignani L, Acquati P, Gadda F, Dell’orto P, Rocco B, Bozzini G, Gazzano G, Morabito A, (2006) Restoration of posterior aspect of rhabdosphincter shortens continence time after radical retropubic prostatectomy. J Urol 175:2201–2206. https://doi.org/10.1016/S0022-5347(06)00262-XCrossRefPubMed

22.

Rocco B, Gregori A, Stener S, Santoro L, Bozzola A, Galli S, Knez R, Scieri F, Scaburri A, Gaboardi F (2007) Posterior reconstruction of the rhabdosphincter allows a rapid recovery of continence after transperitoneal videolaparoscopic radical prostatectomy. Eur Urol 51:996–1003. https://doi.org/10.1016/j.eururo.2006.10.014CrossRefPubMed

23.

Walz J, Burnett AL, Costello AJ, Eastham JA, Graefen M, Guillonneau B, Menon M, Montorsi F, Myers RP, Rocco B, Villers A (2010) A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol 57:179–192. https://doi.org/10.1016/j.eururo.2009.11.009CrossRefPubMed

24.

Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur Urol 70:106–119. https://doi.org/10.1016/j.eururo.2016.02.028CrossRefPubMed

25.

Artibani W, Porcaro AB, De Marco V, Cerruto MA, Siracusano S (2018) Management of biochemical recurrence after primary curative treatment for prostate cancer: a review. Urol Int 100:251–262. https://doi.org/10.1159/000481438CrossRefPubMed

26.

Hung CF, Yang CK, Ou YC (2014) Robotic assisted laparoscopic radical prostatectomy following transurethral resection of the prostate: perioperative, oncologic and functional outcomes. Prostate Int 2:82–89. https://doi.org/10.12954/PI.14046CrossRefPubMedPubMedCentral

27.

Steineck G, Bjartell A, Hugosson J, Axén E, Carlsson S, Stranne J, Wallerstedt A, Persson J, Wilderäng U, Thorsteinsdottir T, Gustafsson O, Lagerkvist M, Jiborn T, Haglind E, Wiklund P, LAPPRO steering committee, (2015) Degree of preservation of the neurovascular bundles during radical prostatectomy and urinary continence 1 year after surgery. Eur Urol 67:559–568. https://doi.org/10.1016/j.eururo.2014.10.011CrossRefPubMed

28.

Reeves F, Preece P, Kapoor J, Everaerts W, Murphy DG, Corcoran NM, Costello AJ (2015) Preservation of the neurovascular bundles is associated with improved time to continence after radical prostatectomy but not long-term continence rates: results of a systematic review and meta-analysis. Eur Urol 68:692–704. https://doi.org/10.1016/j.eururo.2014.10.020CrossRefPubMed

29.

Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, Zattoni F, Association E, of Urology, (2008) EAU guidelines on prostate cancer. Eur Urol 53:68–80. https://doi.org/10.1016/j.eururo.2007.09.002CrossRefPubMed

30.

Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML (2007) Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy. J Urol 178:1277–1280. https://doi.org/10.1016/j.juro.2007.05.153. (discussion 80–81)CrossRefPubMed

31.

Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F (2008) Radical prostatectomy for incidental (stage T1a–T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. Eur Urol 54:118–125. https://doi.org/10.1016/j.eururo.2008.02.018CrossRefPubMed

32.

Herden J, Schwarte A, Boedefeld EA, Weissbach L (2021) Active surveillance for incidental (cT1a/b) prostate cancer: long-term outcomes of the prospective noninterventional HAROW study. Urol Int 105:428–435. https://doi.org/10.1159/000512893CrossRefPubMed

33.

Yossepowitch O, Briganti A, Eastham JA, Epstein J, Graefen M, Montironi R, Touijer K (2014) Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol 65:303–313. https://doi.org/10.1016/j.eururo.2013.07.039CrossRefPubMed

34.

Sofer M, Savoie M, Kim SS, Civantos F, Soloway MS (2003) Biochemical and pathological predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion. J Urol 169:153–156. https://doi.org/10.1097/01.ju.0000042455.02645.d0CrossRefPubMed

35.

Rehman A, El-Zaatari ZM, Han SH, Shen SS, Ayala AG, Miles B, Divatia MK, Ketcham MS, Chung BM, Rogers JT, Ro JY (2020) Seminal vesicle invasion combined with extraprostatic extension is associated with higher frequency of biochemical recurrence and lymph node metastasis than seminal vesicle invasion alone: proposal for further pT3 prostate cancer subclassification. Ann Diagn Pathol 49:151611. https://doi.org/10.1016/j.anndiagpath.2020.151611CrossRefPubMed

Title: Robot-assisted radical prostatectomy following holmium laser enucleation of the prostate: perioperative, functional, and oncological outcomes
Authors: Taro Banno
Kazutaka Nakamura
Akihiko Ozaki
Yukiko Kouchi
Tadashi Ohira
Hiroaki Shimmura
Publication date: 29-05-2023
Publisher: Springer London
Keywords: Prostatectomy
Prostatectomy
Prostate Cancer
Prostate Cancer
Urinary Incontinence
Urinary Incontinence
Benign Prostatic Hypertrophy
Benign Prostatic Hypertrophy
Laser
Published in: Journal of Robotic Surgery / Issue 5/2023
Print ISSN: 1863-2483
Electronic ISSN: 1863-2491
DOI: https://doi.org/10.1007/s11701-023-01621-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Robot-assisted radical prostatectomy following holmium laser enucleation of the prostate: perioperative, functional, and oncological outcomes

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2023

Effect of duration of pneumoperitoneum on renal function in patients undergoing laparoscopic surgeries: a prospective observational study

Surgical outcomes and cost analysis of a multi-specialty robotic-assisted surgery caseload in the Australian public health system

Impact of intraoperative fluid restriction on renal outcomes in patients undergoing robotic-assisted laparoscopic prostatectomy

Robotic-assisted surgery for mid and low rectal cancer: a long but safe learning curve

The safe introduction of robotic surgery in a free-standing children’s hospital

Are new and young generations of surgeons more aware of transoral robotic surgery than older ones? An international survey